KPT-330, a kind of selective inhibitor of nuclear export, could down-regulate XPO1 transcription and reduce the growth capability of HCC cells by increasing the expression of tumor suppressor proteins, such as p53 and p27, in the nucleus and reducing the concentration of oncogenes, such as c-Myc and c-Met [13]. This evidence concerns the gene MYC and hepatocellular carcinoma.